Virtual Event

Targeting Group A Streptococcus for System Improvement

This webinar highlights internal processes regarding diagnostics for Group A Streptococcus, and explains how these results benefit patients, providers, and staff

Wednesday, June 5, 12:30 PM — 1:30 PM EDT

Register Now for Free!

Leveraging near-patient nucleic acid amplification tests (NAAT) in the clinic setting is a growing business practice that many health system laboratories have been hesitant or slow to adopt. Placing highly sensitive and comparatively expensive laboratory testing into the hands of the clinic personnel should carry some measure of reservation. 

After years of hesitancy, our health system has only recently begun to adopt this practice. However, those who leverage appropriate NAATs in the clinic setting with trained laboratory personnel stand to benefit significantly through improved diagnostics and workflow efficiencies. 

A deep dive review of our internal processes regarding diagnostics for Group A Streptococcus provided numerous insights. By adopting a clinic-based NAAT, many benefits can be realized for patients, providers, and staff.


Tyler Radke, MLS(ASCP)CM
Laboratory Manager
Bellin Memorial Hospital and Bellin Health Oconto Hospital

Note: You only need to register once to be signed up for all of the June 2024 Lab Institute talks.

The information you provide will be shared with the sponsor(s) of this content. G2 Intelligence or its sponsor(s) may contact you to offer you content or products based on your interest in this topic. You may unsubscribe from these communications at any time. For information on how to unsubscribe, our privacy practices, and commitment to protecting your privacy, check out our Privacy Policy.